AI-COVID tool could help labs rule out COVID-19
A study conducted by Vermont University and Cedars-Sinai found ‘high accuracy’ in predicting the probability of COVID-19 using Biocogniv’s AI-COVID
software.
The software uses routine blood tests to assist clinical labs with COVID testing, which could help to reduce the number of patients referred for PCR testing.
PCR testing is the current standard diagnostic for COVID-19, but requires specific sampling including nasal swabs and specialised laboratory equipment. Complete Blood Count and Complete Metabolic Panels are common lab tests ordered by emergency departments and have a rapid turnaround time. They can provide insight into the immune system, electrolytes, kidney and liver.
According to researchers, they were able to train a model that analyses changes in these routine tests and assigns a highly accurate probability of the patient being COVID-19 negative. Biocogniv’s chief medical officer Jennifer Joe, an emergency physician in Boston, Massachusetts, said that the software takes just ‘seconds’ to generate its result once blood tests return.
Register now to continue reading
Thanks for visiting The Engineer. You’ve now reached your monthly limit of news stories. Register for free to unlock unlimited access to all of our news coverage, as well as premium content including opinion, in-depth features and special reports.
Benefits of registering
-
In-depth insights and coverage of key emerging trends
-
Unrestricted access to special reports throughout the year
-
Daily technology news delivered straight to your inbox
Experts speculate over cause of Iberian power outages
I´m sure politicians will be thumping tables and demanding answers - while Professor Bell, as reported above, says ´wait for detailed professional...